CoChat

Levetiracetam: Part II, the Clinical Profile of a Novel Anticonvulsant Drug

Open access
De Smedt, Tim, Raedt, Robrecht, Vonck, Kristl, Boon, Paul · 2007 · CNS Drug Reviews
Cited by 104

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The objective of this article was to review and summarize the available reports on the profile of the novel anticonvulsant drug levetiracetam (LEV) in a clinical setting. Therefore, a careful search was conducted in the MEDLINE database and combined with guidelines from regulatory agencies, proceedings of professional scientific meetings, and information provided by the manufacturers. This article is devoted to the clinical pharmacology and clinical trials of LEV investigating its efficacy and safety as add‐on therapy or monotherapy for various seizure types. Finally, results from postmarketing surveillance of LEV are briefly discussed. In general, LEV is shown to be a safe, broad‐spectrum anticonvulsant drug with highly beneficial pharmacokinetic properties, a favorable long‐term retention rate, and a high responder rate, indicating that LEV is an efficient therapeutic option for the treatment of several types of epilepsy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1527-3458.2007.00005.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Equipoise and the Ethics of Clinical Research

    Freedman, B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707163170304 · Cited by 2,339 · cited 2×

    “Still, suboptimal treatment of patients involved in clinical trials is in conflict with the Declaration of Helsinki, one of the major international ethical guidelines for biomedical research involving human subjects, and more specifically with the principle of equipoise, which states that investigators are ethically o…”
    Background

Show all 1 references

Cited by

See all 104

Metadata

Authors
De Smedt, T., Raedt, R., Vonck, K., & Boon, P.
Venue
CNS Drug Reviews
Publisher
Wiley
Published
2007-03
Volume
13
Issue
1
Pages
57-78
ISSN
  • 1080-563X (ISSN-L)
  • 1527-3458
OpenAlex
W2034385122
Cited by
104
References
1
FWCI
4.55
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Levetiracetam: Part II, the Clinical Profile of a Novel Anticonvulsant Drug. https://app.cochat.ai/papers/10.1111/j.1527-3458.2007.00005.x
The paper
De Smedt, T., Raedt, R., Vonck, K., & Boon, P. (2007). Levetiracetam: Part II, the Clinical Profile of a Novel Anticonvulsant Drug. CNS Drug Reviews. https://doi.org/10.1111/j.1527-3458.2007.00005.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.